AM-0715

Known as: AM 0715, AM 715, AM0715 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-1990
012319801990

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Norfloxacin (NFLX, AM-715), a new quinolone antibiotic agent, was evaluated clinically and bacteriologically for its efficacy and… (More)
Is this relevant?
1983
1983
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1983
1983
Norfloxacin is a new organic acid antimicrobic with an expanded spectrum that includes Staphylococcus spp, most Pseudomonas spp… (More)
Is this relevant?
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… (More)
Is this relevant?
1983
1983
1. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a… (More)
  • table 1
  • table 1
  • table 2
Is this relevant?
1982
1982
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… (More)
  • table 1
Is this relevant?
1981
1981
Authors describe structure-activity relationships in quinolone group and report a study of the antibacterial activity of two new… (More)
Is this relevant?
1980
1980
AM-715 [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid] is a new nalidixic acid analog. AM-715… (More)
Is this relevant?